Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
KS

Kohei Shitara

Gastrointestinal oncologist and trial investigator

Appears in 1 story

Notable Quotes

The drug showed a low incidence of gastrointestinal-related toxicity with encouraging anti-tumor effects.

Stories

First CLDN18.2 antibody-drug conjugate reaches regulatory review for gastric cancer

New Capabilities

Reported the trial's safety and efficacy findings

Advanced gastric cancer that returns after treatment usually kills within about six months. On June 4, 2026, Chinese biotech Innovent Biologics said its drug had slowed that clock in a late-stage trial.

Updated 2 hours ago